NO20034588L - Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider - Google Patents

Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider

Info

Publication number
NO20034588L
NO20034588L NO20034588A NO20034588A NO20034588L NO 20034588 L NO20034588 L NO 20034588L NO 20034588 A NO20034588 A NO 20034588A NO 20034588 A NO20034588 A NO 20034588A NO 20034588 L NO20034588 L NO 20034588L
Authority
NO
Norway
Prior art keywords
hla
restricted
materials
methods
cell receptors
Prior art date
Application number
NO20034588A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034588D0 (no
Inventor
Jan Wouter Drijfhout
Frits Koning
Stephan Neil Mcadam
Ludvig Magne Sollid
Original Assignee
Academisch Ziekenhuis Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Leiden filed Critical Academisch Ziekenhuis Leiden
Publication of NO20034588D0 publication Critical patent/NO20034588D0/no
Publication of NO20034588L publication Critical patent/NO20034588L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20034588A 2001-04-12 2003-10-13 Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider NO20034588L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01201377 2001-04-12
EP01204383 2001-11-16
PCT/NL2002/000235 WO2002083722A2 (en) 2001-04-12 2002-04-11 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides

Publications (2)

Publication Number Publication Date
NO20034588D0 NO20034588D0 (no) 2003-10-13
NO20034588L true NO20034588L (no) 2003-12-10

Family

ID=26076879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034588A NO20034588L (no) 2001-04-12 2003-10-13 Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider

Country Status (7)

Country Link
US (1) US20040241161A1 (de)
EP (1) EP1377604B1 (de)
CA (1) CA2443886A1 (de)
IL (1) IL158342A0 (de)
MX (1) MXPA03009313A (de)
NO (1) NO20034588L (de)
WO (1) WO2002083722A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923306D0 (en) 1999-10-01 1999-12-08 Isis Innovation Diagnostic and therapeutic epitope, and transgenic plant
DE60336754D1 (de) * 2002-02-14 2011-05-26 Univ R Enzymbehandlung von nahrungsmitteln für zöliakie-sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
GB0212885D0 (en) 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
ES2383595T3 (es) 2002-11-20 2012-06-22 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de diagnóstico de la celiaquía
BRPI0510274B8 (pt) 2004-04-28 2021-05-25 Btg Int Ltd uso de um agente para tratar ou prevenir doença celíaca, composição farmacêutica compreendendo dito agente, método de diagnóstico de doença celíaca, ou suscetibilidade à doença celíaca, uso do dito agente para a preparação de um meio de diagnóstico e kit para realizar o dito método de diagnóstico
AU2011247868B2 (en) * 2004-04-28 2014-05-22 Btg International Limited Epitopes related to coeliac disease
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
EP1612558A1 (de) * 2004-06-30 2006-01-04 Academisch Ziekenhuis Leiden Verfahren zum Nachweis von Gluten
US8092794B2 (en) * 2006-03-15 2012-01-10 Isocell Pharma S.A. Pharmaceutical compositions comprising SODs and prolamine based peptide fragments
WO2008090126A1 (de) * 2007-01-22 2008-07-31 N-Zyme Biotec Gmbh Getränke für zöliakiepatienten und gluten/gliadin-sensitive personen und verfahren zur herstellung
US20090311727A1 (en) * 2008-04-21 2009-12-17 Bio-Rad Laboratories, Inc. Recombinant deamidated gliadin antigen
EP3269379A1 (de) 2008-11-30 2018-01-17 Immusant, Inc. Zusammensetzungen und verfahren zur behandlung von zöliakie
FR2942409B1 (fr) * 2009-02-20 2013-07-26 Natacha Voillot Composition pharmaceutique pour la prevention des avortements a repetition.
US20140037661A1 (en) * 2011-02-08 2014-02-06 Phadia Ab Wheat Antigens and Peptides for Diagnosis of Wheat Induced Hypersensitivity
EP3171171B1 (de) 2011-12-05 2018-07-18 Bio-rad Laboratories, Inc. Rekombinantes desamidiertes gliadin-antigen
US10449228B2 (en) 2013-09-10 2019-10-22 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
US20200040085A1 (en) * 2017-02-27 2020-02-06 Chugai Seiyaku Kabushiki Kaisha Anti-hla-dq2.5/8 antibody and its use for the treatment of celiac disease
CR20230166A (es) 2020-09-18 2023-05-31 Chugai Pharmaceutical Co Ltd Anticuerpo anti antígenos de leucocitos humanos (hla) isoforma dq 2.5 y su uso para el tratamiento de la enfermedad celíaca

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0905518A1 (de) * 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement

Also Published As

Publication number Publication date
WO2002083722A2 (en) 2002-10-24
CA2443886A1 (en) 2002-10-24
WO2002083722A3 (en) 2003-02-06
MXPA03009313A (es) 2004-11-12
IL158342A0 (en) 2004-05-12
NO20034588D0 (no) 2003-10-13
EP1377604A2 (de) 2004-01-07
EP1377604B1 (de) 2014-12-31
US20040241161A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
NO20034588L (no) Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider
DK1620456T3 (da) Hla-a2 tumor-associerede antigen-peptider og præparater
EP1578432A4 (de) Hla-bindende peptide und deren anwendungen
DK1680443T3 (da) Stabiliserede alfa-helix-peptider og anvendelser heraf
EP1578930A4 (de) Cngh0004-polypeptide, antikörper, zusammensetzungen, verfahren und verwendungen
DK1372686T3 (da) Fremgangsmåder og sammensætninger til peptidsyntese
IL228034A0 (en) Formulations with a high concentration of antibodies and proteins
AU1325102A (en) Protein scaffolds for antibody mimics and other binding proteins
LTPA2010013I1 (lt) Osteoprotegeriną rišantys baltymai ir receptoriai
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
AU2002362586A1 (en) Receptors and membrane-associated proteins
AU2002364699A8 (en) Receptors and membrane-associated proteins
EP1539792A4 (de) Cngh0005-polypeptide, antikörper, zusammensetzungen, verfahren und verwendungen
AU2003222225A8 (en) Receptors and membrane-associated proteins
EP1534332A4 (de) Antikörper und ihre verwendungen
AU2002309970A8 (en) Receptors and membrane-associated proteins
AU2002326910A1 (en) Receptors and membrane-associated proteins
NO20021763D0 (no) Modifiserte peptider og peptiddomimetics for anvendelse ved immunoterapi
DK1448566T3 (da) Kemokinreceptorantagonister og fremgangsmåder til anvendelse deraf
AU2003272799A8 (en) Receptors and membrane-associated proteins
AU2003295437A8 (en) Receptors and membrane-associated proteins
AU2003269884A8 (en) Receptors and membrane-associated proteins
EP1578767A4 (de) Verfahren und materialien zur modulation von trpm2
AU2003262895A8 (en) Carboxypeptidase b related polypeptides and methods of use
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application